HealthcareServices

Microbiome Sequencing Service Market Anticipated to Record Steady Gains, Advancing to $5.29 Billion by 2030

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the microbiome sequencing service market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Microbiome Sequencing Service Market between 2026 and 2030?

The microbiome sequencing service market has seen rapid expansion in recent years. Its projected growth is from $2.43 billion in 2025 to $2.84 billion in 2026, at a compound annual growth rate (CAGR) of 17.1%. The historical growth of this market can be attributed to various factors, including the proliferation of microbiome research initiatives, an increase in academic research funding, a growing interest in studies related to gut and skin microbiota, the widespread availability of next-generation sequencing platforms, and enhanced collaboration between academia and industry.

The microbiome sequencing service market size is projected to experience substantial growth in the upcoming years. It is predicted to expand to $5.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.8%. The expansion during the forecast period is primarily driven by the increasing clinical acceptance of microbiome-based diagnostics, a rise in investments in microbiome therapeutics, the broadening scope of personalized nutrition research, the growing application of AI-driven microbial analysis, and an increasing demand for extensive population microbiome studies. Noteworthy trends for the forecast period include an escalating demand for high-throughput microbiome sequencing services, the increasing adoption of shotgun and amplicon sequencing techniques, the rising incorporation of advanced bioinformatics pipelines, the broadening of clinical microbiome research applications, and an intensified focus on functional microbial profiling.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28270&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Microbiome Sequencing Service Market?

An escalating occurrence of gut-related diseases is anticipated to fuel the expansion of the microbiome sequencing service market in the coming years. These conditions refer to medical issues affecting the gastrointestinal (GI) tract, which encompasses the stomach, intestines, and related organs such as the liver, pancreas, and gallbladder. This uptick in gut-related diseases is attributed to shifts in lifestyle and dietary habits, such as a high intake of processed foods and insufficient fiber, which disturbs the balance of gut microbiota. Microbiome sequencing service assists in managing these diseases by offering detailed insights into the gut’s microbial composition, thus proving valuable for diagnosing and monitoring gastrointestinal conditions. It enables targeted interventions by identifying microbial imbalances, leading to improved personalized treatment and better overall gut health management. For example, in June 2025, the UK Health Security Agency, a UK-based government agency, indicated that laboratory reports for Campylobacter grew by 27.0% from 96.1 to 122.0 per 100,000 population between 2022 and 2024. Hence, the increasing prevalence of gut-related diseases is acting as a key driver for the growth of the microbiome sequencing service market.

What Segments Are Included Within The Microbiome Sequencing Service Market?

The microbiome sequencing service market covered in this report is segmented –

1) By Service: Sample Preparation, Sequencing And Library Preparation, Data Analysis

2) By Technology: Sequencing By Litigation (SBL), Sequencing By Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Other Technologies

3) By Application: Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Other End-Users

Subsegments:

1) By Sample Preparation: Deoxyribonucleic Acid (DNA) Extraction, Ribonucleic Acid (RNA) Extraction, Protein Extraction, Cell Lysis, Library Construction

2) By Sequencing And Library Preparation: Whole Genome Sequencing, Metagenomic Sequencing, Amplicon Sequencing, Shotgun Sequencing, Targeted Sequencing

3) By Data Analysis: Taxonomic Profiling, Functional Profiling, Comparative Analysis, Statistical Analysis, Pathway Analysis

What Trends Are Driving The Growth Trajectory Of The Microbiome Sequencing Service Market?

Companies operating within the microbiome sequencing service market are increasingly focused on developing advanced solutions, such as automated metagenomics sequencing solutions, to enhance efficiency, accuracy, and scalability in microbiome research and analysis. An automated metagenomics sequencing solution is a comprehensive system that allows for the sequencing and analysis of microbial communities with minimal manual intervention, thereby ensuring high accuracy, consistent results, and adaptable throughput. For instance, in July 2024, MGI Tech Co. Ltd., a China-based biotechnology company, unveiled the Human Microbiome Metagenomics Sequencing Package. This product delivers a fully integrated workflow, combining automated sample pretreatment, nucleic acid extraction, library preparation, sequencing, and data analysis, to support high-throughput and cost-efficient microbiome research. Its validated performance on a significant number of human stool samples guarantees both reproducibility and accuracy, setting a new standard for large-scale human microbiome studies.

Who Are The Prominent Global Companies Shaping The Microbiome Sequencing Service Market Landscape?

Major companies operating in the microbiome sequencing service market are Eurofins Scientific LLC, Illumina Inc., Charles River Laboratories, QIAGEN N.V., Mérieux NutriSciences Corporation, OraSure Technologies Inc., Zifo RnD Solutions, Novogene Co. Ltd., Oxford Nanopore Technologies Plc, Macrogen Inc., Zymo Research Corporation, CD Genomics, Molzym GmbH & Co. KG (Gradian Diagnostics), Baseclear BV, Psomagen Inc., Mapmygenome, Rancho Biosciences LLC, Boster Biological Technology Ltd., Clinical Microbiomics, Microba Life Sciences Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/microbiome-sequencing-service-global-market-report

How Does The Microbiome Sequencing Service Market Perform Across Major Global Regions?

North America was the largest region in the microbiome sequencing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome sequencing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Microbiome Sequencing Service Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28270&type=smp

Browse Through More Reports Similar to the Global Microbiome Sequencing Service Market 2026, By The Business Research Company

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Microbiomes Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795